Roche has been pioneering innovative diabetes technologies and services for more than 40 years. More than 4,500 employees in over 100 markets worldwide work every day to support people living with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines.
Being a global leader in integrated Personalized Diabetes Management (iPDM), Roche collaborates with thought leaders around the globe, including people living with diabetes, caregivers, healthcare providers and payers. Roche aims to transform and advance care provision and foster sustainable care structures. Under the brands Accu-Chek and mySugr®, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche unites with its partners to create patient-centered value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualising relevant data points, Roche enables deeper insights and a better understanding of the disease, leading to personalized and effective therapy adjustments. For better outcomes and true relief.